Erin Mcsweeney Buys Shares of UnitedHealth Group
Erin Mcsweeney, EVP & Chief People Officer, acquired 48 shares of UnitedHealth Group.
Key Points
- Erin Mcsweeney, EVP & Chief People Officer at UnitedHealth Group, bought 48 shares on June 23, 2026.
- UnitedHealth Group shares traded near $415.53 on Friday, with a market cap of $369.3 billion and a P/E ratio of 30.65.
- Analysts maintain a 'buy' rating for UnitedHealth Group, with price targets ranging from $440 to $492.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
On June 23, 2026, Erin Mcsweeney, Executive Vice President and Chief People Officer at UnitedHealth Group Incorporated, bought 48 shares of the company. This transaction was not part of a pre-planned trading program. Shares of UnitedHealth Group, trading under the ticker NYSE:UNH, were priced around $415.53 on Friday.
Insider Buying and Selling at UnitedHealth Group Incorporated
In addition to Mcsweeney's purchase, several other insiders at UnitedHealth Group made similar moves on June 23, 2026. Stephen Hemsley, CEO of the company, bought 46 shares, while Christopher Zaetta, EVP & Chief Legal Officer, acquired 61 shares. These transactions were not pre-planned, indicating a potential confidence in the company's future.
Other Institutional Activity in UnitedHealth Group
Institutional investors have also been active in UnitedHealth Group. BlackRock, Inc. reduced its holdings by 1,276,021 shares, leaving it with 73,467,531 shares valued at approximately $19.88 billion, a decrease of 1.7%. Vanguard Capital Management LLC opened a new position with 58,870,777 shares worth about $15.93 billion. State Street Corp added 100,016 shares to its holdings, bringing its total to 45,332,186 shares valued at $12.27 billion, reflecting a 0.2% increase. Capital World Investors increased its stake by 5,192,373 shares to a total of 27,783,415 shares, valued at $7.52 billion, marking a 23% rise.
UnitedHealth Group Incorporated Stock Up 5.7%
Shares of UnitedHealth Group (NYSE:UNH) traded near $415.53 on Friday. The company boasts a market capitalization of $369.3 billion and has a P/E ratio of 30.65. The stock's 52-week range spans from $234.60 to $415.98, with a 50-day moving average of $372.67 and a 200-day moving average of $333.55. UnitedHealth Group maintains a current ratio of 0.798, a quick ratio of 0.722, and a debt-to-equity ratio of 73.98.
$UNH stock price
Daily closing prices, year to date. Not investment advice.
Recent Earnings
UnitedHealth Group reported revenue of $449.71 billion, reflecting a growth rate of 2%. The company achieved an EPS of $13.27, with a net margin of 2.68% and a return on equity of 12.18%. The next earnings report is anticipated on July 16, 2026.
Dividend
UnitedHealth Group pays an annual dividend of $9.28, yielding 2.31% with a payout ratio of 66.57%.
Analysts Set New Price Targets
Analysts have been bullish on UnitedHealth Group. On June 24, 2026, B of A Securities maintained a 'buy' rating with a price target of $475. Similarly, Leerink Partners and Mizuho both maintained 'buy' ratings with targets of $462 and $460, respectively. The consensus among 26 analysts is a 'buy' recommendation, with an average price target of $409.77.
About UnitedHealth Group
UnitedHealth Group Incorporated is a leading healthcare company based in Eden Prairie, Minnesota. It operates through segments such as Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare, offering a range of health-related services and products. With a workforce of 390,000, the company provides care delivery, health plans, and pharmacy services across the United States and internationally.
Bottom Line
Erin Mcsweeney's recent purchase of UnitedHealth Group shares highlights insider confidence in the company's trajectory. The stock is trading near its 52-week high, reflecting strong market performance. With analysts maintaining a favorable outlook, UnitedHealth Group remains a closely watched player in the healthcare sector. Remember, insider transactions are disclosed after the fact and may not predict future stock movements.
Get UnitedHealth Group Incorporated alerts
New 13F filings, insider trades, and analyst moves on $UNH, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.